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Joan Manils1, Eduard Casas2,3, Arnau Vin˜a-Vilaseca1, Marc Lo´pez-Cano1,4, Anna Dı´ez-Villanueva2,
Diana Go´mez1, Laura Marruecos1, Marta Ferran5, Carmen Benito6, Fred W. Perrino7, Tanya Vavouri2,3,
Josep Maria de Anta1, Francisco Ciruela1,4 and Concepcio´ Soler1Trex2 is a keratinocyte-specific 30-deoxyribonuclease that participates in the maintenance of skin homeostasis
after DNA damage. Here, we show that this exonuclease is strongly upregulated in human psoriasis, a
hyperproliferative and inflammatory skin disease. Similarly, the imiquimod (IMQ)- and Il23-induced mouse
psoriasis was associated with a substantial upregulation of Trex2, which was recruited into fragmented chro-
matin in keratinocytes that were undergoing impaired proliferation, differentiation, and cell death, indicating
an important role in DNA processing. Using Trex2 knockout mice, we have found that Trex2 deficiency
attenuated IMQ-induced psoriasis-like skin inflammation and enhanced IMQ-induced parakeratosis. Also,
Il23-induced ear swelling was diminished in Trex2 knockout mice in comparison with wild-type (wt) mice.
Transcriptome analysis identified multiple genes that were deregulated by Trex2 loss after treatment with IMQ.
Specifically, immune response genes and pathways normally associated with inflammation were down-
regulated, whereas those related to skin differentiation and chromatin biology showed increased expression.
Interestingly, Trex2 deficiency led to decreased IMQ-induced keratinocyte death via both cell autonomous
and noncell autonomous mechanisms. Hence, our data indicate that Trex2 acts as a critical factor in the
pathogenesis of psoriasis by promoting keratinocyte apoptosis and enucleation and thereby influencing skin
immune responses.
Journal of Investigative Dermatology (2016) 136, 2345e2355; doi:10.1016/j.jid.2016.05.122INTRODUCTION
Psoriasis is a chronic and relapsing inflammatory skin disease
that currently has no cure and that affects approximately 2% of
the population. The etiology of this disease relies on both ge-
netic and environmental factors, but our knowledge regarding
these mechanisms remains incomplete. Defective keratino-
cyte proliferation and differentiation programs, aberrant im-
mune responses, and dermal angiogenesis are the major
factors that have been implicated in its pathogenesis. Activa-
tion of particular subsets of skin dendritic cells leads to IL23
upregulation (Glitzner et al., 2014; Lande et al., 2007; Nestle
et al., 2005; Wohn et al., 2013), which triggers IL17/IL22
production by T helper 17/22 cells and a subset of gd T cells
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genes, including proinflammatory cytokines, chemokines, and
antimicrobial peptides, which amplify immune circuits,
accelerate keratinocyte turnover, and impact epidermal dif-
ferentiation (Lowes et al., 2014; Wagner et al., 2010).
A growing amount of data has shown that self-nucleic acid
homeostasis and sensing play a central role in the initiation
and maintenance of chronic inflammation (Demaria et al.,
2014; Paludan, 2015). Notably, the binding of self-DNA to
CAMP/LL-37, which is strongly upregulated in psoriasis,
regulates nucleic acid-driven activation of both dendritic
cells (Dombrowski et al., 2011; Lande et al., 2007) and
TNF-a-primed keratinocytes (Chiliveru et al., 2014).
Skin injuries, infections, chemicals, and other cell
stressors can prime psoriasis onset, linking the release of
DNA during keratinocyte death to the development of dis-
ease pathogenesis (Lowes et al., 2014). Indeed, cytosolic
DNA in keratinocytes and extracellular DNA associated with
neutrophil extracellular traps are found in psoriatic skin but
are not detected in healthy skin (Dombrowski et al., 2011;
Lin et al., 2011). It is of note that nucleases are implicated
in the free nucleic acid degradation and these have been
involved in inflammatory diseases (Grieves et al., 2015;
Kawane et al., 2006; Napirei et al., 2000; Yang et al.,
2007), but their role in psoriasis still remains undefined.
Interestingly, the DNA exonuclease TREX2 is one of the genes
that is most highly enriched in psoriatic lesions compared
with normal skin (Li et al., 2014). Furthermore, Trex2
expression is restricted to keratinocytes, where it contributes
to approximately half of the 30-exonuclease activity of the
epidermis (Parra et al., 2009).estigative Dermatology. This is an open access
-nc-nd/4.0/). www.jidonline.org 2345
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2346TREX2 biochemistry, its molecular structure, and its DNA
binding and hydrolysis properties have been largely charac-
terized (Chen et al., 2007; de Silva et al., 2009; Mazur and
Perrino, 2001; Perrino et al., 2005, 2008), but less is known
about its physiological role. Studies in heterologous cellular
systems have shown that TREX2 may condition several DNA
repair mechanisms (Aubert et al., 2014; Bennardo et al., 2009;
Huet al., 2013).Neither spontaneous tumors norchromosomal
instability has been observed in Trex2/ mice (Parra et al.,
2009). However, Trex2 deficiency in mice leads to increased
susceptibility to carcinogen-induced skin tumorigenesis
(Manils et al., 2015; Parra et al., 2009), indicating a critical role
for this exonuclease in the skin homeostasis on DNA damage.
Here, we demonstrate that Trex2 further contributes to the
pathogenesis of psoriasis by promoting DNA degradation,
keratinocyte death, and skin inflammation.
RESULTS
TREX2 expression is upregulated and disrupted in human
psoriasis
Our analysis of TREX2 expression in available human psori-
atic transcriptomes (Nair et al., 2009; Reischl et al., 2007;
Suarez-Farinas et al., 2012; Yao et al., 2008) indicated the
significantly strong upregulation of this exonuclease in
lesional psoriatic skin compared with normal and nonle-
sional skin (Supplementary Figure S1a and b online). In
contrast, the expression levels of other nucleases, such as the
closely related TREX1 exonuclease, the keratinocyte-specific
DNase1L2 nuclease, and polymerases carrying proofreading
exonuclease activity, were similar between psoriasis and
normal skin. Furthermore, in agreement with the findings in
gene expression studies in cytokine-stimulated human
keratinocytes (Li et al., 2014), we observed that Trex2
protein levels increased in mouse keratinocytes after
treatment with Il17a and Tnf-a (Supplementary
Figure S1c), which are key triggers of psoriasis-mediated
inflammation. In addition, in the imiquimod (IMQ)- and
Il23-induced mouse models of psoriasis, we have demon-
strated that Trex2 mRNA expression, compared with that of
Trex1 and Dnase1l2, was highly increased (Supplementary
Figure S1d and e), in concordance with transcriptome anal-
ysis of the IMQ- (Swindell et al., 2011) and Il23-treated
(Sua´rez-Farin˜as et al., 2013) mouse skin. Therefore, these
data suggest that TREX2 can be a putative player in the
pathogenesis of psoriasis.
To analyze TREX2 deregulation in human psoriasis, we
evaluated TREX2 mRNA and protein expression levels in
normal, nonlesional, and psoriatic skin samples (Figure 1). The
two human TREX2 mRNA transcripts were highly upregulated
in psoriatic skin (Figure 1a). Intriguingly, western blot analysis
of total and immunoprecipitated protein extracts derived from
psoriatic skin samples revealed a major polypeptide band of
approximately 26 kDa, which corresponded to the expected
molecular weight of the short isoform, and a minor band of
approximately 19 kDa but not the 31 kDa band corresponding
to the molecular weight predicted for the long isoform
(Figure 1b). As a control, cDNAs encoding long (L) and short (S)
isoforms were ectopically expressed in human HaCaT kerati-
nocyte cells, and these did not express detectable levels of
endogenous TREX2 protein. The cDNA for the short isoformJournal of Investigative Dermatology (2016), Volume 136gave rise to the expected 26 kDa isoform, and the cDNA for the
long isoform was translated into three polypeptides with mo-
lecular weights of approximately 31, 29, and 26 kDa. These
three polypeptides may have resulted from the use of alterna-
tive translation start sites at positions 1, 16, and 44 of the 279-
amino-acid isoform. In addition, the 19 kDa band detected in
psoriatic skin samples could have arisen from the use of the
next downstreammethionine, located at position 107 from the
N-terminus of the long isoform. However, we could not
exclude that it might also have been a proteolytic product. In
human epidermal keratinocyte cultures, only the expression of
the 26 kDa isoform and the corresponding mRNA transcript
were detected. In these cultures, TREX2 expression was
induced during keratinocyte differentiation, indicated by the
expression of the keratinocyte late differentiation maker IVL
(Supplementary Figure S2aec online). Altogether, these data
indicate that the 26 kDa TREX2 is the predominant isoform
expressed in both normal and psoriatic human skin. Notably,
immunofluorescence analysis (Figure 1c) illustrated TREX2
overexpression and disturbed distribution in psoriatic
epidermis. In normal and nonlesional skin, TREX2 was abun-
dantly expressed in the uppermost keratinocyte skin layers,
specifically in the stratum granulosum of the interfollicular
epidermis and the hair shaft. However, in psoriatic skin lesions,
characterized by an expansion of the spinous-granular layers
and the premature expression of keratinocyte differentiation-
related genes, such as IVL (Figure 1c, Guttman-Yassky et al.,
2009), strong TREX2 staining was observed in almost all
suprabasal layers of the hyperproliferative epidermis and in the
parakeratotic stratum corneum. Specifically, TREX2 accumu-
lated in the nuclei of differentiating, proliferating, and dying
psoriatic keratinocytes (Figure 1d).
Trex2 accumulates in the upper layers of the hyperplasic
epidermis and the hyperkeratotic and parakeratotic stratum
corneum in IMQ-treated skin and is recruited to fragmented
chromatin
Resembling human psoriasis, immunofluorescence analysis
showed a strong Trex2 staining in the IMQ-induced
psoriasis-like mouse skin. In untreated skin, in the telogen
(Figure 2a) and anagen phases of the hair growth cycle
(Supplementary Figure S3a online), Trex2 accumulated in
the uppermost epidermal layers, the inner root sheath of the
hair follicle, and the apical region of the sebaceous glands
(Supplementary Figure S3b), all of which are locations where
the last stages of keratinocyte differentiation take place (Fuchs,
2007). After 4 days of treatment with IMQ, Trex2
was heterogeneously expressed in the regenerating epidermal
layers and hypertrophied sebaceous glands beneath micro-
abscesses and in various upper layers in both the hyperplasic
epidermis and the hyperkeratotic and parakeratotic stratum
corneum. Similarly, in Il23-treated ears, Trex2 accumulated in
multiple upper layers (Figure 2b). In contrast, the expression of
Krt10, an early keratinocyte differentiation-related gene, was
mainly detected in follicular keratinocytes and in the outer
layer of the hyperkeratotic stratum corneum of IMQ-treated
skin. Interestingly, in the interfollicular hyperplasic
epidermis, Krt10 staining was widely expressed in the upper
layers in Trex2-deficient skin, whereas it was only detected in
sporadic keratinocytes in wild-type (wt) skin (Figure 2a),
Figure 1. TREX2 expression is
upregulated in human psoriasis.
TREX2 expression was evaluated in
normal, nonlesional, and psoriatic
human skin, preconfluent (pre-C) and
day 8 postconfluent (d8-pC) normal
human epidermal keratinocytes
(NHEK) cultures, and HaCaT cells
transfected with the cDNAs coding for
the long (L) and short (S) human
TREX2 (hTREX2) isoforms. (a) Relative
mRNA expression levels for L and S
transcripts. Mean  SEM of three
normal and three psoriatic samples
and four NHEK cultures. (b) TREX2
protein expression was analyzed in
total extracts and immunoprecipitates
(IP). Antibody specificity was
contrasted using preimmune (PI)
serum and recombinant hTREX2. (c)
Representative immunofluorescence
images showing TREX2, IVL, and
nuclei labeling. (d) Highly magnified
inset of panel (c). *, proliferating
and <, dying keratinocytes; >,
corneocytes; dotted lines, epidermal-
dermal border; dashed lines, stratum
corneum. Scale bars ¼ 100 mm (c), 50
mm (d).
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IMQ-induced skin differentiation patterns.
Although substantial amounts of Trex2 protein were pre-
sent in the cytosol, Trex2 accumulated in keratinocyte
nuclei and corneocyte nuclear remnants (Figure 2c), as
described above in human psoriasis. Notably, immunofluo-
rescence costaining for Trex2, fragmented DNA (TUNEL),
and nuclei (DAPI) showed Trex2-TUNEL colocalization in
some corneocyte nuclear remnants. These were more abun-
dant in Trex2/ IMQ-treated skin than in treated wt skin
(Figure 2c). This suggests that Trex2 actively participates in
fragmented DNA degradation. Nuclear removal during
cornification is a very rapid process (Eckhart et al., 2013), and
the transitional cells that were double-labeled with Trex2
and TUNEL were relatively difficult to detect. Interestingly,costaining with phosphorylated H2ax (gH2ax), a marker of
DNA double-strand breaks (Rogakou et al., 1998), revealed
that Trex2 was recruited into regions containing fragmented
chromatin in suprabasal keratinocyte nuclei (Figure 2d).
Collectively, these data support a crucial role for Trex2
promoting the degradation of fragmented DNA during pso-
riasis development.
Trex2 loss attenuates psoriatic inflammation and increases
parakeratosis
To determine whether Trex2 played an important role in the
complex pathogenesis of psoriasis, the IMQ-induced mouse
model of transient psoriasis was used (van der Fits et al.,
2009). Notably, the IMQ-induced psoriasis-like phenotype
was attenuated in Trex2/ skin compared with wt skin.www.jidonline.org 2347
Figure 2. Trex2 expression is
induced in the IMQ- and Il23-treated
skin, and it is recruited to regions of
fragmented chromatin. (a) Trex2
(red), Krt10 (green), and nuclei
(blue) staining in skin sections
from wt and Trex2/ mice that were
untreated or treated for 4 days with
IMQ. (b) Trex2 (red) and nuclei (blue)
staining in ear sections from wt mice
that were treated for 6 days with
phosphate buffered saline (control) or
Il23. (c) TUNEL (red), Trex2 (green),
and nuclei (blue) labeling in
parakeratotic stratum corneum regions
from wt and Trex2/ mice that were
treated for 4 days with IMQ. Arrows
indicate Trex2 and TUNEL
costaining. (d) Single confocal section
illustrating costaining between Trex2
and gH2ax in a representative
epidermis section from IMQ-treated
wt mice at day 4. *, proliferating
and <, dying keratinocytes; >
corneocytes; dotted lines, epidermal-
dermal border; dashed lines, stratum
corneum; continuous lines, sebaceous
gland. Scale bars ¼ 100 mm (a, b), 25
mm (c, d). IMQ, imiquimod; wt, wild
type.
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2348Erythema, scaling scores, and thickening were significantly
lower on days 3 and 4 in the IMQ-treated Trex2/ skin
than in wt skin (Figure 3aec). Consistent with these results,
by day 4, IMQ-induced epidermal myeloid microabscess
formation was markedly attenuated in the Trex2/ skin
compared with wt skin (Figure 3d and e). By day 8, no
microabscesses were present in either the IMQ-treated wt
skin, as has previously been described (van der Fits et al.,
2009), or the IMQ-treated Trex2/ skin, indicating that
loss of Trex2 did not result in a delayed inflammatory
response. Interestingly, hematoxylin and eosin staining also
revealed that treated Trex2/ skin exhibited a significantJournal of Investigative Dermatology (2016), Volume 136increase in parakeratosis on day 4 compared with wt skin
and that a slight increase remained on day 8, indicating that
Trex2 may be involved in nuclear DNA degradation during
the abnormal keratinocyte terminal differentiation that oc-
curs in psoriasis. Thus, Trex2 deficiency protected mice
from IMQ-induced myeloid infiltration but promoted IMQ-
induced parakeratosis. In agreement with a proin-
flammatory role of Trex2 in psoriasis, Il23-induced ear
swelling was significantly lower in Trex2/ mice
compared with wt mice (Figure 3f), and correlated with
reduced levels of dermal infiltration in the absence of Trex2
(Figure 3g).
Figure 3. Trex2L/L mice show
altered IMQ- and Il23-induced
psoriatic phenotypes.Wt and Trex2/
mice were treated daily with IMQ
applied to shaved back skin. (a) Skin
severity is represented as cumulative
erythema and scaling scores. (b) Skin
thickening was measured as the
double-skinfold thickness. (c)
Representative images of IMQ-induced
lesions at day 4. (d) Representative
hematoxylin and eosin (H&E)-stained
skin sections from untreated and IMQ-
treated mice at 4 and 8 days. The insets
show high magnifications of
microabscess and parakeratosis-affected
regions. (e) Microabscesses and
parakeratosis were evaluated as a
percentage relative to the length of the
epidermis. Mean  SEM of at least
four untreated mice and six IMQ-
treated mice for each genotype. (f) Ear
thickness of wt and Trex2/ mice
injected intradermally with IL23- or
phosphate buffered saline (PBS) was
measured daily for 6 days. Mean 
SEM of six (wt) and seven Trex2/
treated mice. (g) Representative H&E-
stained ear sections from IL23-treated
wt and Trex2/ mice at 6 days.
Significant differences between
genotypes: two-way analysis of
variance t-test (##, P < 0.01; ###,
P < 0.001). Scale bars ¼ 100 mm (d),
200 mm (g). IMQ, imiquimod;
SEM, standard error of the mean;
wt, wild type.
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immune, differentiation, cell death, chromatin modifier, and
DNA repair genes in IMQ-induced psoriasis
To determine the mechanisms underlying Trex2 activity in
psoriasis, we performed whole-transcriptome sequencing
using IMQ-treated skin on day 4. We identified 621 genes
that were significantly differentially expressed between
IMQ-treated Trex2/ and wt skin. Among the pathways
found differentially enriched in gene set enrichment anal-
ysis, there were three that might be associated with psoriasis
pathology: immune responses, skin differentiation, andchromatin biology (Figure 4a, Supplementary Figure S4 and
Table S1 online). In particular, genes and pathways associ-
ated with inflammation, including immune cell chemotaxis
and activation, cell killing, cell defenses, interferon re-
sponses, Il17, and apoptosis, were clearly downregulated in
the absence of Trex2. Conversely, genes and pathways
related to epidermal development and differentiation, DNA
repair, and chromatin biology showed significantly
increased expression (Figure 4b and c). In addition, those
involved in lipid metabolism pathways were increased,
whereas those involved in redox regulation pathways werewww.jidonline.org 2349
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2350decreased in Trex2-deficient mice (Supplementary
Figure S4).
The expression of selected genes in major pathways that
were differentially regulated according to genotype was
further confirmed using quantitative RT-PCR (Figure 4d).
Consistent with the milder IMQ-induced inflammatory
phenotype that was observed in the absence of Trex2
(Figure 3), immune genes that have been previously impli-
cated in the development of psoriasis, such as theFigure 4. Trex2-dependent
deregulated genes and pathways in
the IMQ-induced psoriasis. RNA-seq
data generated from the skin of IMQ-
treated wt and Trex2/mice at day 4.
(a) Enrichment map. The depleted
pathways in Trex2/ skin compared
with wt skin are shown in blue, and
those that were enriched are shown in
red. The displayed pathways are
significantly below a P value threshold
of 0.005 and a false discovery rate of
0.0075. (b) Violin plots of all of the
genes in each annotated pathway,
shown as ranked, from more to less
correlated with Trex2 deficiency. (c)
Heatmap expression plot of selected
genes. (d) Relative mRNA expression
of the indicated genes. Mean  SEM
of at least four untreated and six IMQ-
treated mice for each genotype.
Significant differences, by a two-way
analysis of variance t-test between
genotypes: #, P < 0.05; ##, P < 0.01,
and compared with IMQ-treated
samples: *, P < 0.05; **, P < 0.01;
***, P < 0.001. IMQ, imiquimod;
SEM, standard error of the mean;
wt, wild type.
Journal of Investigative Dermatology (2016), Volume 136antimicrobial peptides S100a8, S100a9, and Camp/Ll-37, the
cytokines Il23a, Tnf-a, and Il1a, the chemokines Ccl5
and Cxcl10, and many Ifn-stimulated genes, were
expressed at lower levels in IMQ-treated Trex2/ skin
compared with treated wt skin. Despite the fact that the
mRNA levels of the cytokines Il17a, Il17f, and Il17c were
similarly induced by IMQ in wt and Trex2/ skins at this
time point, Il17 signature genes, including the S100 peptides
and T-cell-specific CD3 genes, were decreased by the loss of
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Trex2 Promotes Inflammation in PsoriasisTrex2. Moreover, in agreement with the differential immune
response observed in the absence of Trex2, immunofluo-
rescence staining of Elane-, CD11c-, and CD3-positive
cells showed that neutrophils, dermal dendritic cells, and T
lymphocytes were less abundant in the IMQ-treated Trex2/
skin than in treated wt skin (Figure 5a). In addition, Il17
immunostaining revealed fewer amounts of Il17-positve
neutrophils (ElaneþIl17þ cells) in the IMQ-treated Trex2/
skin than in treated wt skin (Figure 5a). It is of note
that increasing evidence indicates a predominant role of
preformed IL17 protein from neutrophils, as an early source
of IL17-dependent inflammatory pathologies, such as psori-
asis (Cua and Tato, 2010; Lin et al., 2011). Because the
attenuation of the IMQ-induced inflammatory phenotype
caused by the loss of Trex2 was observed for the first days of
treatment, it is tempting to speculate that Trex2 could be
contributing mainly to the early inflammatory response,
when neutrophil recruitment and inflammation can be acti-
vated in the absence of the Il17 receptor (El Malki et al.,
2013). In fact, the acute IMQ-induced psoriasis inflamma-
tory phenotype mostly reflects early events in psoriasis
pathogenesis rather than chronic T-cell-mediated disease
(Flutter and Nestle, 2013).
Additionally, consistent with a role of Trex2 in the IMQ-
induced altered epidermal differentiation program, the differ-
entiation marker Ivl was expressed at higher levels in
IMQ-treatedTrex2/ skin than in treatedwt skin (Figure 4c and
d). Accordingly, Ivl staining was barely detected in IMQ-
treated wt skin, whereas strong labeling was observed in the
upper keratinocyte layers in treated Trex2/ skin (Figure 5b).
Trex2 promotes IMQ-induced keratinocyte death through
both cell autonomous and noncell autonomous mechanisms
IMQ-driven inflammation has also been associated with
IMQ-induced cell death (Flutter and Nestle, 2013; Schon
et al., 2004). Importantly, transcriptome analysis showed
significantly reduced expression of Gzma and Gzmb,
two apoptotic proteases that are mainly contained in
natural killer and T-cell granules, in IMQ-treated Trex2/
skin compared with treated wt skin (Figure 4c and d). Hence,
Trex2 deficiency may lead to markedly decreased cytotoxic
lymphocyte-mediated cell death, which is in agreement with
the above-mentioned reduced amounts of T lymphocytes in
IMQ-treated Trex2/ skin compared with treated wt skin
(Figure 5a). Furthermore, western blot assays demonstrated
that apoptosis, assessed by analyzing Casp3 cleavage, was
significantly reduced in both IMQ-treated Trex2/ skin
and keratinocyte cultures compared with treated wt samples
(Figure 5c and d). Altogether, these data indicate that TREX2
promotes IMQ-induced keratinocyte death by both cell-
autonomous and non-cell-autonomous mechanisms.
DISCUSSION
Our results demonstrate that TREX2, a keratinocyte-specific
exonuclease, is strongly upregulated in both human psori-
asis and the murine models of IMQ- or Il23-induced
psoriasis. In the hyperplasic and parakeratotic regions of
psoriatic epidermis, Trex2 is recruited to fragmented chro-
matin, where it plays a crucial role in DNA degradation
during keratinocyte death either via apoptosis orcornification processes. Trex2 deficiency leads to decreased
keratinocyte apoptosis, which attenuates skin inflammation.
A model describing the role of Trex2 in IMQ-induced pso-
riasis is shown in Supplementary Figure S5 online. Similarly,
recent data in mouse models have indicated that necroptotic
and apoptotic keratinocyte death can trigger skin inflam-
mation (Kumari et al., 2014; Panayotova-Dimitrova et al.,
2013; Rickard et al., 2014). A diversity of signals are
released by dying cells, including nucleic acids and IL1a,
and these can act as potent inducers and amplifiers of in-
flammatory responses (Lowes et al., 2014; Pasparakis et al.,
2014). Additionally, the absence of Trex2 results in the
retention of nuclei in corneocytes and a subsequent increase
in parakeratosis. In agreement with descriptions of an
interplay between nuclear degradation and keratinocyte
differentiation (Naeem et al., 2015; Yamamoto-Tanaka et al.,
2014), our data have revealed significant differences in the
expression of genes that are related to skin differentiation
between wt and Trex2/ IMQ-treated skin. Remarkably, we
observed a significant IMQ-induced decrease in Ivl expres-
sion, contrasting with the huge increased expression seen in
human psoriasis, pointing to the known limitation of mouse
models to accurately recapitulate the full transcriptome
profile and all features of human psoriasis, such as the
aberrant keratinocyte differentiation and proliferation
(Lowes et al., 2014).
Many studies in mouse models have supported crucial
roles for several DNases in cellular homeostasis and
inflammation, but whether they play relevant roles in the
onset and development of psoriasis is largely unknown.
Expression data indicate that the exonuclease TREX2 seems
to be the only DNase that is strongly upregulated in psoriasis.
The multifunctional endonuclease APE1, which is involved in
both DNA repair and redox signaling, has been shown to be
moderately upregulated in psoriasis, where it acts as an
intrinsic modulator of keratinocyte inflammatory responses
(Lee et al., 2009). The keratinocyte-specific endonuclease
DNase1L2, which has been involved in nuclear DNA
degradation during cornification of human keratinocytes
in vitro (Fischer et al., 2007), but not mouse interfollicular
keratinocytes in vivo (Fischer et al., 2011), is not expressed in
psoriatic parakeratosis (Fischer et al., 2007), and its mRNA is
only slightly increased in psoriasis. Additionally, no dramatic
changes were observed in the expression of the ubiquitous
nucleases that are required to maintain the steady-state
degradation of DNA, including endonuclease Dnase I,
which is responsible for breaking down extracellular DNA
(Napirei et al., 2000), the lysosomal endonuclease Dnase II,
which is involved in the clearance of engulfed apoptotic
nuclei (Kawane et al., 2001, 2003) and damaged nuclear
DNA (Lan et al., 2014), and the exonuclease Trex1, which is
implicated in cytoplasmic DNA degradation (Gehrke et al.,
2013; Stetson et al., 2008). Deficiencies in these nucleases
lead to the accumulation of self-DNA, which triggers a strong
type I IFN signature and results in autoinflammatory
diseases (Gall et al., 2012; Grieves et al., 2015; Yoshida et al.,
2005). In contrast, Trex2 deficiency dampened the inflam-
matory response in an IMQ-induced psoriasis-like mouse
model, and in response to ultraviolet-B radiation (Manils
et al., 2015). These data support a nonredundant positivewww.jidonline.org 2351
Figure 5. Disrupted inflammation, differentiation, and apoptosis in IMQ-treated Trex2L/L skin. (a) Representative CD3, CD11c, Elane, and Il17 staining
and relative amount of CD3þ, CD11cþ, Elaneþ, and ElaneþIl17þ cells in IMQ-treated wt and Trex2/ skin at day 4. Mean  SEM for six mice from
each genotype. (b) Representative immunofluorescence images of Trex2 (red), Ivl (green), and nuclei (DAPI, blue) labeling in skin sections from IMQ-treated
wt and Trex2/ skin at day 4. (c) Representative blots of Casp3 in wt and Trex2/ skin and keratinocytes untreated or IMQ-treated for the indicated
times. (d) Mean  SEM of cleaved Casp3 relative to Actb from six mice of each genotype and in keratinocytes from two independent experiments. Significant
differences between genotypes: two-way analysis of variance t-test (#, P < 0.05; ##, P < 0.01). Scale bars ¼ 100 mm (a), 50 mm (b). IMQ, imiquimod; SEM,
standard error of the mean; wt, wild type.
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responses under stress conditions.
The increase in IMQ-induced parakeratosis and the
decrease in intrinsic keratinocyte apoptosis in Trex2-
deficient mice, along with the accumulation of Trex2 in
damaged chromatin, indicate that this exonuclease is a
critical player in the aberrant DNA degradation processes
that occur in psoriatic skin. Paradoxically, even though
Trex2 deficiency leads to the accumulation of nondegraded
DNA, there is a concomitant decrease in DNA-driven im-
mune responses, such as the type I interferon signature. It is
likely that the confinement in the stratum corneum of non-
degraded corneocyte nuclei prevents the release, engulf-
ment, and further sensing of self-DNA by plasmacytoid
dendritic cells. These cells, known to be major producers of
type I IFNs, are involved in the initiation of psoriasis
(Gilliet and Lande, 2008; Glitzner et al., 2014; Lande et al.,
2007). Remarkably, it has been shown that inflammasome
activation by shorter DNA fragments was stronger than by
longer fragments (Dombrowski et al., 2011). Also, the
DNase II-mediated digestion of genomic DNA into short
oligonucleotides is required for endosomal sensing by Tlr9
(Chan et al., 2015). Furthermore, in support of an impor-
tant role for DNA processing in the regulation of im-
mune responses, it has been reported that a lack of DNA
degradation by the nuclease CAD, which is responsible
for the cell-autonomous chromosomal cleavage of
apoptotic nuclei, does not trigger Ifn responses (Kawane
et al., 2003). Thus, because Trex2 intrinsically promotes
keratinocytes to undergo IMQ-induced Casp3-dependent
apoptosis, which leads to Cad-mediated chromosomal
cleavage, it is tempting to hypothesize that the Trex2
exonuclease could contribute to the shortening of long
fragments of apoptotic DNA, which further facilitates the
recognition of released DNA by plasmacytoid dendritic
cells and the subsequent DNA-driven inflammatory
response that is associated with psoriatic inflammation.
Interestingly, in the absence of Trex2, the IMQ-induced
genes and pathways related to chromatin condensation and
repair were significantly enriched, supporting an important
role for this exonuclease in chromatin homeostasis. This is in
agreement with previous data demonstrating that Trex2 in-
teracts with gH2ax (Manils et al., 2015), a critical player in
both DNA repair and DNA degradation (Baritaud et al., 2010;
Lu et al., 2006). Additionally, it has been shown that TREX2
can modulate DNA double-strand break repair (Bennardo
et al., 2009) and replication fork stalling after DNA damage
(Hu et al., 2013). Thus, our transcriptome data support a role
for Trex2 in chromatin biology under stress conditions, such as
those induced by either IMQ or DNA damage. Future studies
should determine whether the effects of Trex2 on chromatin
biology are associated with its exonuclease activity or its
DNA-binding capacity or are related to currently unknown
interactions and functions. Interestingly, proteins that are
strongly upregulated in psoriatic epidermis, such as the anti-
microbial peptides S100A9 and CAMP, mediate psoriasis in
part by interacting with chromatin and thereby modulating,
directly or indirectly, the expression of immune-related genes
(Chiliveru et al., 2014; Dombrowski et al., 2011; Lande et al.,
2007; Schonthaler et al., 2013).In conclusion, our work indicates that Trex2 shapes pso-
riatic phenotypes by contributing to DNA degradation during
aberrant keratinocyte turnover, thereby promoting keratino-
cyte apoptosis and skin inflammation. Collectively, our data
reveal that TREX2 is a key player in psoriasis pathology and
highlight this exonuclease as a potential keratinocyte-specific
therapeutic target for diminishing psoriatic inflammation.
MATERIALS AND METHODS
Human samples
Skin biopsies were obtained from patients diagnosed with psoriasis
and from healthy controls. Samples were embedded in optimal
cutting temperature compound and frozen. The study was approved
by the Medical Ethics Committee of the Hospital del Mar (Barcelona,
Spain) according to the Declaration of Helsinki principles, and
written, informed consent was obtained from all participants.
Mice and treatments
The Trex2/ mouse has been described previously (Parra et al.,
2009). Trex2/ and wt C57BL/6 mice were bred and housed in a
specific pathogen-free environment according to the requirements of
the Ethics Committee on Animal Care of Parc Cientı´fic of Barcelona.
All experiments were conducted under the authorization of the
Catalan Government (DAAM 7171, DAAM 8835, and DAAM 8962).
The IMQ- and the Il23-induced mouse models of psoriasis were
performed as previously described (Hara-Chikuma et al., 2015; van
der Fits et al., 2009) in female mice aged 8 to 10 weeks. Full details
are given in Supplementary Materials and Methods online.
Keratinocyte cultures
Mouse and human keratinocyte cultures and treatments are detailed
in Supplementary Materials and Methods.
Immunostaining, microscopic imaging
For skin immunostaining analyses, immunohistochemistry and in-
direct immunofluorescence standard procedures were used (detailed
in Supplementary Materials and Methods).
Protein extracts, immunoprecipitation, and western blot
analysis
Protein extracts, immunoprecipitation, and western blot analysis
were performed as previously described (Parra et al., 2009) and are
detailed in Supplementary Materials and Methods.
RNA isolation and quantitative RT-PCR analysis
Total RNA from pulverized skin samples was extracted using a
NucleoSpin-RNA kit (Machery-Nagel, Du¨ren, Germany), and
quantified and analyzed using a NanoDrop ND-1000 Spectropho-
tometer. The samples were assayed using an ABI7500 Fast-Real Time
PCR system (Applied Biosystems, Bleiswijk, The Netherlands). The
results are presented relative to those for the housekeeping genes
HPRT1 or Sdha using the DCq method. Predesigned probes and gene
primers for human and mouse genes are detailed in Supplementary
Materials and Methods.
RNA-Seq and data analysis
mRNA was selected from total RNA using an mRNA direct kit
(Thermo Fisher Scientific, Waltham, MA) and used to produce the
RNA-Seq cDNA library according to standard protocols, including
the addition of adaptors (detailed in Supplementary Materials and
Methods). To analyze gene expression levels, reads were assigned
to overlapping genes using the tool featureCounts (Liao et al., 2014).
Specific mouse annotation included the Reactome pathway data-
base v53 (Joshi-Tope et al., 2005) and the Gene Ontology databasewww.jidonline.org 2353
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2354(Ashburner et al., 2000) obtained in July 2015. The DESeq2 package
v1.8.1 (Love et al., 2014) for R-3.2.0 (R Core Team 2015) was used
to identify genes that were differentially expressed between wt and
Trex2/ IMQ-treated skin. Read counts scaling, normalization, and
tests for differential expression were performed using the default
tools included in this software. Pathway enrichment tests were run
using Gene Set Enrichment Analysis v2.0 (Subramanian et al., 2005)
with default parameters. Violin plots and heat map representations
were produced using the library gplots v2.17.0 (Warnes et al., 2015)
for R. We loaded the results into Cytoscape v2.8.3 (Shannon et al.,
2003) and used the Enrichment Map plugin v1.2 (Merico et al.,
2010) to build the network-based map for proper gene-set enrich-
ment visualization and interpretation. The RNA-Seq data discussed
in this article were deposited in the GEO repository (GSE74528).
Statistics
The two-way analysis of variance test with a Bonferroni post-test was
applied for comparisons between mouse genotypes or treatment
conditions. All tests were two-tailed. The Wilcoxon pairwise and the
Kruskall Wallis comparison tests with multiple testing corrections
were applied to determine significant differences between two or
three groups, respectively, to analyze publicly available gene
expression databases. DESeq2 by default calculates significance
using the Wald test and corrects for false discovery rates using
Benjamini-Hochberg corrections. P values of  0.05 were consid-
ered to be statistically significant.
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